Healx is a biotechnology company that specializes in using artificial intelligence to accelerate the discovery and development of treatments for rare diseases. The company focuses on leveraging its proprietary technology platform to identify and repurpose existing drugs, aiming to bring new therapies to patients more efficiently. Healx collaborates with various stakeholders, including academic institutions and pharmaceutical companies, to enhance drug development processes and improve patient outcomes in the rare disease space.